Selective addition of CXCR3+CCR4-CD4+ Th1 cells enhances generation of cytotoxic T cells by dendritic cells in vitro

Experimental and Molecular Medicine

Volumn 41, Issue 3, 2009, Pages 161-170

  Yoon, Sung Hee ^a   Yun, Sun Ok ^a   Park, Jung Yong ^a   Won, Hee Yeun ^a   Kim, Eun Kyung ^a   Sohn, Hyun Jung ^a   Cho, Hyun Il ^a   Kim, Tai Gyu ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Adoptive transfer; Antigens; Dendritic cells; Differentiation; Immunotherapy, adoptive; Maturation; Receptors, CCR4; Receptors, CXCR3; T lymphocytes, cytotoxic; Th1 cells; Th2 cells

Indexed keywords

B7 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; WT1 PROTEIN;

ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL LINE; CELL MATURATION; CELL POLARITY; CELL SECRETION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PROTEIN EXPRESSION; TH1 CELL;

EID: 65949112915     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.3.019     Document Type: Article

References (33)

1. Chattopadhyay S, Chakraborty NG. Continuous presence of Th1 conditions is necessary for longer lasting tumor- specific CTL activity in stimulation cultures with PBL. Hum Immunol 2005;66:884-891 (Pubitemid 41416533)
2. Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, Romagnani S. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol 2000;30:2972-2979
3. Eiz-Vesper B, Horn PA, Daubert C, Khattab B, Blasczyk R. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells. Transfusion 2006;46:1210-1220 (Pubitemid 44139496)
4. Frick JS, Zahir N, Muller M, Kahl F, Bechtold O, Lutz MB, Kirschning CJ, Reimann J, Jilge B, Bohn E, Autenrieth IB. Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: An important role for IL-6. Eur J Immunol 2006;36:1537-1547
5. Gao FG, Khammanivong V, Liu WJ, Leggatt GR, Frazer IH, Fernando GJ. Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell. Cancer Res 2002;62:6438 (Pubitemid 35364102)
6. Gentao L, Hiushan N, Yasuharu A, Xiangpeng Y, Moneeb E, Dong Y, Keith LB, John SY. Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response. Eur J Immunol 2004;34:1680-1687 (Pubitemid 39256050)
7. Giuntoli RL 2nd, Lu J, Kobayashi H, Kennedy R, Celis E. Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function. Clin Cancer Res 2002;8:922-931
8. Hoffmann TK, Meidenbauer N, Muller-Berghaus J, Storkus WJ, Whiteside TL. Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells. J Immunother 2001;24:162-171 (Pubitemid 32183062)
9. Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, Griffith TS, Green DR, Schoenberger SP. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005;434:88
10. Jin Y, Fuller L, Wei Y, Blomberg BB, Miller J, Esquenazi V. Bone marrow cells promote TH2 polarization and inhibit virus-specific CTL generation. Hum Immunol 2000;61:1233-1241 (Pubitemid 32102411)
11. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, Butcher EC. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001;108:1331-1339 (Pubitemid 33107761)
12. Kim CH, Nagata K, Butcher EC. Dendritic cells support sequential reprogramming of chemoattractant receptor profiles during naive to effector T cell differentiation. J Immunol 2003a;171:152-158
13. Kim J, Choi SP, La S, Seo JS, Kim KK, Nam SH, Kwon B. Constitutive expression of 4-1BB on T cells enhances CD4+ T cell responses. Exp Mol Med 2003b;35:509-517
14. Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother 2005;54:721-728 (Pubitemid 40977140)
15. Larmonier N, Marron M, Zeng Y, Cantrell J, Romanoski A, Sepassi M, Thompson S, Chen X, Andreansky S, Katsanis E. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol Immunother 2007;56:48-59
16. Lim D, Bourcier KB, Freeman G, et al. Examination of CD8+ T cell function in humans using MHC class I tetramers: similar cytotoxicity but variable proliferation and cytokine production among different clonal CD8+ T cells specific to a single viral epitope. J Immunol 2000;165:6214-6220
17. Lukacs NW. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 2001;1:108
18. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002;23:445-449
19. Lyakh LA, Sanford M, Chekol S, Young HA, Roberts AB. TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells. J Immunol 2005;174:2061-2670 (Pubitemid 40223949)
20. Mackay CR. Chemokine receptors and T cell chemotaxis. J Exp Med 1996;184:799-802 (Pubitemid 26313537)
21. Mocellin S. Priming anticancer active specific immunotherapy with dendritic cells. Curr Opin Investig Drugs 2005;6:576-581 (Pubitemid 40852290)
22. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173 (Pubitemid 19138011)
23. Nishimura T, Iwakabe K, Sekimoto M, Ohmi Y, Yahata T, Nakui M, Sato T, Habu S, Tashiro H, Sato M, Ohta A. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo. J Exp Med 1999;190:617 (Pubitemid 29428646)
24. Osada T, Morse MA, Lyerly HK, Clay TM. Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs. Int Immunol 2005;17:1143-1155
25. Ostankovitch M, Le Gal FA, Connan F, Chassin D, Choppin J, Guillet JG. Generation of Melan-A/MART-1-specific CD8+ cytotoxic T lymphocytes from human naive precursors: helper effect requirement for efficient primary cytotoxic T lymphocyte induction in vitro. Int J Cancer 1997;72:987-994 (Pubitemid 27433563)
26. Palucka AK, Laupeze B, Aspord C, Saito H, Jego G, Fay J, Paczesny S, Pascual V, Banchereau J. Immunotherapy via dendritic cells. Adv Exp Med Biol 2005;560:105-114 (Pubitemid 43759182)
27. Prilliman KR, Lemmens EE, Palioungas G, Wolfe TG, Allison JP, Sharpe AH, Schoenberger SP. Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL. J Immunol 2002;169:4094-4097 (Pubitemid 35178176)
28. Sato T, Terai M, Yasuda R, Watanabe R, Berd D, Mastrangelo MJ, Hasumi K. Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy. Cancer Immunol Immunother 2004;53:53-61 (Pubitemid 38161181)
29. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997;159:4772-4780 (Pubitemid 127471012)
30. Surman DR, Dudley ME, Overwijk WW, Restifo NP. Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen. J Immunol 2000;164:562
31. Voigtlander C, Rossner S, Cierpka E, Theiner G, Wiethe C, Menges M, Schuler G, Lutz MB. Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J Immunother 2006;29:407-415
32. Ward SG, Bacon K, Westwick J. Chemokines and T lymphocytes: more than an attraction. Immunity 1998;9:1-11 (Pubitemid 28361290)
33. Zhang Y, Wakita D, Chamoto K, Narita Y, Matsubara N, Kitamura H, Nishimura T. Th1 cell adjuvant therapy combined with tumor vaccination: a novel strategy for promoting CTL responses while avoiding the accumulation of Tregs. Int Immunol 2007;19:151-161 (Pubitemid 46179010)